Determinants of effective vaccine coverage in low and middle-income countries: A systematic review and interpretive synthesis

BMC Health Services Research

Volumn 17, Issue 1, 2017, Pages

  Phillips, David E ^a   Dieleman, Joseph L ^a   Lim, Stephen S ^a   Shearer, Jessica ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b PATH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHILD; DEVELOPING COUNTRY; HUMAN; PATIENT ATTITUDE; PREVENTIVE HEALTH SERVICE; STATISTICS AND NUMERICAL DATA; UTILIZATION; VACCINATION;

CHILD; DEVELOPING COUNTRIES; HUMANS; IMMUNIZATION PROGRAMS; PATIENT ACCEPTANCE OF HEALTH CARE; VACCINATION;

EID: 85029866966     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/s12913-017-2626-0     Document Type: Review

References (122)

1. World Health Organization, UNICEF, World Bank. State of the world's vaccines and immunization [Internet]. 3rd ed. Geneva, Switzerland: WHO; 2009. Available from: http://apps.who.int/iris/bitstream/10665/63027/1/WHO-GPV-96.04.pdf
2. Jha P, Chaloupka FJ, Moore J, Gajalakshmi V, Gupta PC, Peck R, et al. Disease control priorities in developing countries. 2nd ed. New York: Oxford University Press; 2006.
3. Abubakar II, Tillmann T, Banerjee A. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;385(9963):117-71.
4. Harris JB, Gacic-Dobo M, Eggers R, Brown DW, Sodha SV, Control C. For D, et al. global routine vaccination coverage, 2013. MMWR Morb Mortal Wkly Rep. 2014;63(46):1055-8.
5. Restrepo-Méndez MC, Barros AJ, Wong KL, Johnson HL, Pariyo G, França GV, et al. Inequalities in full immunization coverage: trends in low-and middle-income countries. Sierra. 2016;3(1.3):0-005.
6. Centers for Disease Control and Prevention. CDC Health Information for International Travel 2014: The Yellow Book. New York: Oxford University Press; 2013.
7. Cutts FT, Smith PG, Colombo S, Mann G, Ascherio A, Soares AC. Field evaluation of measles vaccine efficacy in Mozambique. Am J Epidemiol. 1990;131(2):349-55.
8. Rudner Lugo N. The Relationships among Service Delivery Factors, Community Characteristics, and Immunization Completion by Two-Year-Old Children Using County Health Departments [Internet]. 1993 [cited 2017 Jun 13]. Available from: http://elibrary.ru/item.asp?id=5765487
9. Falagas ME, Zarkadoulia E. Factors associated with suboptimal compliance to vaccinations in children in developed countries: a systematic review. Curr Med Res Opin. 2008;24(6):1719-41.
10. Rainey JJ, Watkins M, Ryman TK, Sandhu P, Bo A, Banerjee K. Reasons related to non-vaccination and under-vaccination of children in low and middle income countries: findings from a systematic review of the published literature, 1999-2009. Vaccine. 2011;29(46):8215-21.
11. LaFond A, Kanagat N, Steinglass R, Fields R, Sequeira J, Mookherji S. Drivers of routine immunization coverage improvement in Africa: findings from district-level case studies. Health Policy Plan. 2014;298-308. czu011.
12. Patriarca PA, Wright PF, John TJ. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev Infect Dis. 1991;13(5):926-39.
13. Akande TM. A review of measles vaccine failure in developing countries. Niger Med Pract. 2007;52(5-6):112-6.
14. Cherry JD. Why do pertussis vaccines fail? Pediatrics. 2012;129(5):968-70.
15. World Health Organization. Monitoring the building blocks of health systems: a handbook of indicators and their measurement strategies [Internet]. [cited. Jun 13. 2017; Available from: http://www.who.int/healthinfo/systems/monitoring/en/
16. World Health Organization. Principles and considerations for adding a vaccine to a national immunization programme: from decision to implementation and monitoring. [Internet]. World Health Organization; 2014. Available from: https://www.cabdirect.org/cabdirect/abstract/20153178719
17. Hyde TB, Dentz H, Wang SA, Burchett HE, Mounier-Jack S, Mantel CF, et al. The impact of new vaccine introduction on immunization and health systems: a review of the published literature. Vaccine. 2012;30(45):6347-58.
18. Naimoli JF, Challa S, Schneidman M, Kostermans K. Toward a grounded theory of why some immunization programmes in sub-Saharan Africa are more successful than others: a descriptive and exploratory assessment in six countries. Health Policy Plan. 2008;23(6):379-89.
19. Dixon-Woods M, Agarwal S, Jones D, Young B, Sutton A. Synthesising qualitative and quantitative evidence: a review of possible methods. J Health Serv Res Policy. 2005;10(1):45-53.
20. Dixon-Woods M, Cavers D, Agarwal S, Annandale E, Arthur A, Harvey J, et al. Conducting a critical interpretive synthesis of the literature on access to healthcare by vulnerable groups. BMC Med Res Methodol. 2006;6(1):35.
21. Health Systems Evidence [Internet]. Available from: https://www.healthsystemsevidence.org /.
22. Cochrane Library [Internet]. [cited 2017 Jun 13]. Available from: http://www.cochranelibrary.com/
23. Systematic Reviews [Internet]. [cited 2017 Jun 13]. Available from: https://systematicreviewsjournal.biomedcentral.com/
24. Agency for Healthcare Research & Quality [Internet]. [cited 2017 Jul 24] Available from: https://www.ahrq.gov/
25. University of York. Centre for Reviews and Dissemination [Internet]. [cited 2017 Jun 13]. Available from: https://www.york.ac.uk/crd/
26. EPPI-Centre [Internet]. [cited 2017 Jun 13]. Available from: https://eppi.ioe.ac.uk/cms/
27. Ryman TK, Dietz V, Cairns KL. Too little but not too late: results of a literature review to improve routine immunization programs in developing countries. BMC Health Serv Res. 2008;8(1):134.
28. Johri M, Pérez MC, Arsenault C, Sharma JK, Pai NP, Pahwa S, et al. Strategies to increase the demand for childhood vaccination in low-and middle-income countries: a systematic review and meta-analysis. Bull World Health Organ. 2015;93(5):339-46.
29. Tickner S, Leman PJ, Woodcock A. Factors underlying suboptimal childhood immunisation. Vaccine. 2006;24(49):7030-6.
30. Mills E, Jadad AR, Ross C, Wilson K. Systematic review of qualitative studies exploring parental beliefs and attitudes toward childhood vaccination identifies common barriers to vaccination. J Clin Epidemiol. 2005;58(11):1081-8.
31. Haddad S, Bicaba A, Feletto M, Taminy E, Kabore M, Ouédraogo B, et al. System-level determinants of immunization coverage disparities among health districts in Burkina Faso: a multiple case study. BMC Int Health Hum Rights. 2009;9(1):S15.
32. Bbaale E. Factors influencing childhood immunization in Uganda. 2013; Available from: https://tspace.library.utoronto.ca/handle/1807/50572
33. Mays N, Roberts E, Popay J. Synthesising research evidence. In: Studying the organisation and delivery of health services: research methods. London, UK: Routledge; 2001. p. 188-220.
34. Barnett-Page E, Thomas J. Methods for the synthesis of qualitative research: a critical review. BMC Med Res Methodol. 2009;9(1):59.
35. Noblit GW, Hare RD. Meta-ethnography: Synthesizing qualitative studies, vol. Vol. 11. USA: Sage; 1988.
36. Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50(2):179-211.
37. Gauri V, Khaleghian P. Immunization in developing countries: its political and organizational determinants. World Dev. 2002;30(12):2109-32.
38. Chen L. Primary health care in developing countries: overcoming operational, technical, and social barriers. Lancet. 1986;328(8518):1260-5.
39. Agot GN. The determinants of measles vaccination in Kenya [internet]: University of Nairobi; 2014. Available from: http://erepository.uonbi.ac.ke/handle/11295/76659
40. Rosenstock IM. Why people use health services. Milbank Q. 2005;83(4):94-127.
41. Katz IT, Ware NC, Gray G, Haberer JE, Mellins CA, Bangsberg DR. Scaling up human papillomavirus vaccination: a conceptual framework of vaccine adherence. Sex Health. 2010;7(3):279-86.
42. Gerend MA, Shepherd JE. Predicting human papillomavirus vaccine uptake in young adult women: comparing the health belief model and theory of planned behavior. Ann Behav Med. 2012;44(2):171-80.
43. Kastner M, et al. The capture-mark-recapture technique can be used as a stopping rule when searching in systematic reviews. J Clin Epidemiol. 2009;62(2):149-157.
44. Gavi Full-Country Evaluation Team. Process evaluation of pneumococcal vaccine introduction in Mozambique, Uganda, and Zambia [internet]. Gavi alliance; 2014. Available from: http://www.gavi.org/Library/GAVI-documents/Evaluations/Process-evaluation-report-of-Pneumococcal-Vaccine-Introduction-in-Mozambique,-Uganda-and-Zambia/
45. Abdulraheem IS, Onajole AT, Jimoh AAG, Oladipo AR. Reasons for incomplete vaccination and factors for missed opportunities among rural Nigerian children. J Public Health Epidemiol. 2011;3(4):194-203.
46. Tagbo BN, Eke CB, Omotowo BI, Onwuasigwe CN, Onyeka EB, Mildred UO, et al. Vaccination coverage and its determinants in children aged 11-23 months in an Urban District of Nigeria. World J Vaccines. 2014;4(04):175.
47. Reach V. Starting at the last mile: rethinking medical supply chains in low-income countries [internet]. Seattle, USA: Village Reach; 2012. Available from: http://www.villagereach.org/wp-content/uploads/2012/03/02272012.Starting-at-the-Last-Mile-Whitepaper.pdf
48. Jani JV, De Schacht C, Jani IV, Bjune G. Risk factors for incomplete vaccination and missed opportunity for immunization in rural Mozambique. BMC Public Health. 2008;8(1):161.
49. Norwegian Agency for Development Cooperation. Alleviating System Wide Barriers to Immunization: Issues and conclusions from the Second GAVI Consultation with Country Representatives and Global Partners [Internet]. Geneva, Switzerland: GAVI Alliance; 2004. Available from: http://www.gavi.org/library/publications/other-publishers/other/alleviating-system-wide-barriers-to-immunization/
50. Dowling P. Healthcare Supply Chains in Developing Countries: Situational Analysis. Arlingt Va USAID Deliv Proj [Internet]. 2011; Available from: https://peoplethatdeliver.org/ptd/sites/default/files/resource-contents-files/Healthcare%20Supply%20Chains%20-%20Situation%20Analysis%20EN.pdf
51. Fatiregun AA, Okoro AO. Maternal determinants of complete child immunization among children aged 12-23 months in a southern district of Nigeria. Vaccine. 2012;30(4):730-6.
52. Ecumenical Pharmaceutical Network. Effective pharmaceutical supply chains: On the road in low income countries [Internet]. EPN; 2011. Available from: http://apps.who.int /medicinedocs/documents/s19965en/s19965en.pdf.
53. Oya-Ita A, Nwachukwu CE, Oringanje C, Meremikwu MM. Interventions for improving coverage of child immunization in low-income and middle-income countries. Cochrane Database Syst Rev. 2009;(7):DOI: 10.1002/14651858.CD008145.pub2.
54. Omutanyi RM, Mwanthi MA. Determinants of immunisation coverage in Butere-Mumias district, Kenya. East Afr Med J. 2005;82(10):501-5.
55. Cheyne J. Vaccine delivery management. Rev Infect Dis. 1989;11(Supplement 3):S617-22.
56. DeRoeck D, Levin A. Review of financing of immunization programs in developing and transitional countries. 1998 [cited 2017 Jun 13]; Available from: http://www.popline.org/node/532199
57. Kamanda BC. Immunization coverage and factors associated with failure to complete childhood immunization in Kawempe division, Uganda [internet]. University of the Western Cape; 2010. Available from: http://etd.uwc.ac.za/xmlui/handle/11394/2595
58. Uddin MJ, Larson CP, Oliveras E, Khan AI, Quaiyum MMA, Chandra SN. Child immunization coverage in rural hard-to-reach Haor areas of Bangladesh: possible alternative strategies. Asia Pac J Public Health. 2009;21(1):8-18.
59. Kawakatsu Y, Honda S. Individual-, family-and community-level determinants of full vaccination coverage among children aged 12-23 months in western Kenya. Vaccine. 2012;30(52):7588-93.
60. Subramanyam K. Vaccine distribution: an operations research study. Rev Infect Dis. 1989;11(Supplement 3):S623-S628.
61. Calhoun LM, van Eijk AM, Lindblade KA, Odhiambo FO, Wilson ML, Winterbauer E, et al. Determinants and coverage of vaccination in children in western Kenya from a 2003 cross-sectional survey. Am J Trop Med Hyg. 2014;90(2):234-41.
62. Weir E, Hatch K. Preventing cold chain failure: vaccine storage and handling. Can Med Assoc J. 2004;171(9):1050-0.
63. Haidari LA, Connor DL, Wateska AR, Brown ST, Mueller LE, Norman BA, et al. Augmenting transport versus increasing cold storage to improve vaccine supply chains. PLoS One. 2013;8(5):e64303.
64. Matthias DM, Robertson J, Garrison MM, Newland S, Nelson C. Freezing temperatures in the vaccine cold chain: a systematic literature review. Vaccine. 2007;25(20):3980-6.
65. Tsu VD. Overcoming barriers and ensuring access to HPV vaccines in low-income countries. Am J Law Med. 2009;35(2-3):401-13.
66. Sia D, Kobiané JF, Sondo BK, Fournier P. Individual and environmental characteristics associated with immunization of children in rural areas in Burkina Faso: a multi-level analysis. Sante Montrouge Fr. 2006;17(4):201-6.
67. Ataguba JE, Ojo KO, Ichoku HE. Explaining socio-economic inequalities in immunization coverage in Nigeria. Health Policy Plan. 2016;31(9):1212-24.
68. Burns IT, Zimmerman RK. Immunization barriers and solutions. J Fam Pract. 2005;54(1):S58-8.
69. Shea B, Andersson N, Henry D. Increasing the demand for childhood vaccination in developing countries: a systematic review. BMC Int Health Hum Rights. 2009;9(1):S5.
70. Brugha RF, Kevany JP. Maximizing immunization coverage through home visits: a controlled trial in an urban area of Ghana. Bull World Health Organ. 1996;74(5):517.
71. Ruair BRUGHA, Kevany J. Immunization determinants in the eastern region of Ghana. Health Policy Plan. 1995;10(3):312-8.
72. Uddin M, Larson CP, Oliveras E, Khan AI, Quaiyum MA, Saha NC, et al. Effectiveness of combined strategies to improve low coverage of child immunization in urban slums of Bangladesh [Internet]. International Centre for Diarrhoeal Diseases Research Bangladesh: Dhaka; 2008. Available from: http://dspace.icddrb.org/jspui/bitstream/123456789/3358/1/ICDDRBWorkingpaper-169-UddinMJ.pdf
73. Perry H, Nurani S, Quaiyum MA, Jinnah SA, Sharma A, others. Barriers to immunization among women and children living in slums of Zone 3 of Dhaka city, Bangladesh: a qualitative assessment [Internet]. International centre for diarrhoeal disease research (ICDDR, B); 2007. Available from: https://www.researchgate.net/profile/Anjali-Sharma14/publication/237579070-Barriers-to-Immunization-among-Women-and-Children-Living-in-Slums-of-Zone-3-of-Dhaka-City-Bangladesh-A-Qualitative-Assessment/links/555ef98108ae8c0cab2c95b1.pdf
74. Cutts FT, Diallo S, Zell ER, Rhodes P. Determinants of vaccination in an urban population in Conakry. Guinea Int J Epidemiol. 1991;20(4):1099-106.
75. Strobino D, Keane V, Holt E, Hughart N, Guyer B. Parental attitudes do not explain underimmunization. Pediatrics. 1996;98(6):1076-83.
76. Bosch-Capblanch X, Banerjee K, Burton A. Unvaccinated children in years of increasing coverage: how many and who are they? Evidence from 96 low-and middle-income countries. Tropical Med Int Health. 2012;17(6):697-710.
77. LaMontagne DS, Barge S, Thi Le N, Mugisha E, Penny ME, Gandhi S, et al. Human papillomavirus vaccine delivery strategies that achieved high coverage in low-and middle-income countries. Bull World Health Organ. 2011;89(11):821-30.
78. Odusanya OO, Alufohai EF, Meurice FP, Ahonkhai VI. Determinants of vaccination coverage in rural Nigeria. BMC Public Health. 2008;8(1):381.
79. Cutts FT, Rodrigues LC, Colombo S, Bennett S. Evaluation of factors influencing vaccine uptake in Mozambique. Int J Epidemiol. 1989;18(2):427-33.
80. Khan A, Quaiyum MA, Gazi R, Uddin J, Ahmed F, Islam M, et al. Programmatic and non-programmatic determinants of low immunization coverage in Bangladesh. In: Presentation made at Forum. 2005.
81. Opollo M-S, Makumbi F, Mukanga D, Namusisi O, Ayebazibwe N, Tweheyo R. Factors associated with DPT 1-3 vaccine dropout in Kabarole district, western Uganda. Int J Infect Dis. 2010;14:e453-4.
82. Kamau N, Esamai FO. Determinants of immunization coverage among children in Mathare Valley. Nairobi East Afr Med J. 2001;78(11):590-4.
83. Maina LC, Karanja S, Kombich J. Immunization coverage and its determinants among children aged 12-23 months in a peri-urban area of Kenya. Pan Afr Med J. 2013;14(1)
84. Matthews Z, Diamond I. Child immunisation in Ghana: the effects of family, location and social disparity. J Biosoc Sci. 1997;29(03):327-43.
85. Schoeps A, Ouedraogo N, Kagone M, Sie A, Müller O, Becher H. Socio-demographic determinants of timely adherence to BCG, Penta3, measles, and complete vaccination schedule in Burkina Faso. Vaccine. 2013;32(1):96-102.
86. Gonçalves A, Ferrinho P, Aguiar P. Factors associated with vaccine status and health services consultation of children from a rural area of Guinea Bissau. Acta Medica Port. 2001;14(3):331-5.
87. Sackou KJ, Oga AS, Desquith AA, Houenou Y, Kouadio KL. Complete immunization coverage and reasons for non-vaccination in a periurban area of Abidjan. Bull Soc Pathol Exot. 2012;105(4):284-90.
88. de Waroux OLP, Schellenberg JRA, Manzi F, Mrisho M, Shirima K, Mshinda H, et al. Timeliness and completeness of vaccination and risk factors for low and late vaccine uptake in young children living in rural southern Tanzania. Int Health. 2013;5(2):139-47.
89. Mohammad M. Determinants of the utilization of the tetanus toxoid (TT) vaccination coverage in Bangladesh: evidence from a Bangladesh demographic health survey 2004. Internet J Health. 2008;8
90. Alfredsson R, Svensson E, Trollfors B, Borres MP. Why do parents hesitate to vaccinate their children against measles, mumps and rubella? Acta Paediatr. 2004;93(9):1232-7.
91. Laval B, Fascia P, Gocko X, Feuillet J, Lucht F. Determinants of vaccination coverage for children and teenagers. Médecine Mal Infect. 2011;41(7):359-63.
92. Ayebazibwe N. Immunization coverage and risk factors for high dropout in Rakai district. 2009; Available from: http://dspace.mak.ac.ug/handle/10570/1174
93. du Loû AD, Pison G. Barriers to universal child immunization in rural Senegal 5 years after the accelerated expanded Programme on immunization. Bull World Health Organ. 1994;72(5):751.
94. Milstien JB, Gibson JJ. Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safety. Bull World Health Organ. 1990;68(1):93.
95. Kimati VP, Loretu K, Munube GMR, Kimboi F. Others. The problem of measles virus response with reference to vaccine viability, age, protein energy malnutrition and malaria in the tropics. J Trop Pediatr. 1981;27(4):205-9.
96. Rogers B, Dennison K, Adepoju N, Dowd S, Uedoi K. Vaccine cold chain: part 1. Proper handling and storage of vaccine. AAOHN J. 2010;58(8):337-46.
97. Khare S, Dutta M, Lal B, Kumari S. Quality control of cold chain system potency testing of oral polio vaccine. For Comm Bull. 1988;5:9-13.
98. Briggs H, Ilett S. Weak link in vaccine cold chain. BMJ. 1993;306(6877):557.
99. Centers for Disease Control and Prevention. Guidelines for maintaining and managing the vaccine cold chain. MMWR Morb Mortal Wkly Rep. 2003;52(42):1023.
100. Wang D-Y, Yang R-I, Yang Y-C, Yeh S-Y, Chen T-L, Cheng H-F, et al. The relationship between the cold chain system and vaccine potency in Taiwan:(I) Live measles vaccine and MMR vaccine. J Food Drug Anal. 1999;7(3):233-42.
101. Zipursky S, Boualam L, Cheikh DO, Fournier-Caruana J, Hamid D, Janssen M, et al. Assessing the potency of oral polio vaccine kept outside of the cold chain during a national immunization campaign in Chad. Vaccine. 2011;29(34):5652-6.
102. Organization WH, others. Safe vaccine handling, cold chain and immunizations: A manual for the newly independent states [Fact sheet]. 1998.
103. Oyefolu AO, Nwaeke AC, Audu RA, Akinyemi KO, Salu OB, Muller CP, et al. Evaluation of measles vaccine cold chain in Lagos state. Nigeria Afr J Clin Exp Microbiol. 2007;8(1):1-7.
104. Wang D-Y, Yang R-I, Yang Y-C, Yeh S-Y, Chen T-L, Cheng H-F, et al. The relationship between the cold chain system and vaccine potency in Taiwan:(II) Oral polio vaccine. J Food Drug Anal. 2000;8(1):17-23.
105. Deshpande JM, Rao VK, Nadkarni SS, Bhatia JP, Rodrigues JJ. An evaluation of cold chain in Maharashtra & Karnataka states by potency testing of field samples of oral poliovirus vaccine. Indian J Med Res. 1995;102:60-5.
106. Pickering LK, Wallace G, Rodewald L. Too hot, too cold: issues with vaccine storage. Pediatrics. 2006;118(4):1738-9.
107. Gold MS, Kemp AE, Osbourne M. Counting the cost of disrupting the vaccine cold chain. Med J Aust. 1998;168(9):471-2.
108. Thakker Y, Woods S. Storage of vaccines in the community: weak link in the cold chain? BMJ. 1992;304(6829):756-8.
109. Camacho-Amor ML, Valdespino-Gomez JL, Ayala-Gonzalez M, Diaz-Ortega JL, Gonzalez-Velazquez MS, Morales-Romo A, et al. Evaluation of the cold chain and follow-up of the potency of the antimeasles vaccine in the field. Bol Med Hosp Infant Mex. 1990;47(7):506-11.
110. Samant Y, Lanjewar H, Parker D, Block L, Tomar GS, Stein B. Evaluation of the cold-chain for oral polio vaccine in a rural district of India. Public Health Rep. 2007;122(1):112-21.
111. World Health Organization. Study protocol for temperature monitoring in the vaccine cold chain (WHO document WHO/IVB/05.01). Geneva WHO. 2005;4-11.
112. Islam M, Islam M. A study on vaccine cold chain monitoring. J Preven Soc Med. 1993;12:53-9.
113. Cheriyan E. Monitoring the vaccine cold chain. Arch Dis Child. 1993;69(5):600-1.
114. Rogers B, Dennison K, Adepoju N, Dowd S, Uedoi K. Vaccine cold chain: part 2. Training personnel and program management. AAOHN J Off J Am Assoc Occup Health Nurses. 2010;58(9):391-400.
115. Carr C, Byles J, Durrheim D, others. Practice nurses best protect the vaccine cold chain in general practice. Aust J Adv Nurs. 2009;27(2):35.
116. von Hedenström M, Kahler W. The cold chain from manufacturer to vaccinator: experiments and experiences. Vaccine. 1992;10(13):949-51.
117. World Health Organization. Global Programme for Vaccines and Immunisation, Expanded Programme on Immunisation. Module; 1998.
118. Knoll MD, Park DE, Johnson TS, Chandir S, Nonyane BAS, Conklin L, et al. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on immunogenicity. Pediatr Infect Dis J. 2014;33:S119-29.
119. Gregson AL, Edelman R. Does antigenic overload exist? The role of multiple immunizations in infants. Immunol Allergy Clin N Am. 2003;23(4):649-64.
120. Hess G, Hingst V, Cseke J, Bock HL, Clemens R. Influence of vaccination schedules and host factors on antibody response following hepatitis B vaccination. Eur J Clin Microbiol Infect Dis. 1992;11(4):334-40.
121. Bruguera M, Rodicio JL, Alcazar JM, Oliver A, Del Rio G, Esteban-Mur R. Effects of different dose levels and vaccination schedules on immune response to a recombinant DNA hepatitis B vaccine in haemodialysis patients. Vaccine. 1990;8:S47-9.
122. Poland GA. Variability in immune response to pathogens: using measles vaccine to probe immunogenetic determinants of response. Am J Hum Genet. 1998;62(2):215-20.